BlackRock, Inc. (BLK) 13D/13G Filings for Theravance Biopharma, Inc. (TBPH)

BlackRock, Inc. 13D and 13G filings for Theravance Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-30
1:14 pm
Purchase		 2025-03-31 13G Theravance Biopharma, Inc.
TBPH		 BlackRock Inc.
BLK		 3,235,696
6.500%		 3,235,696increase
(New Position)		 Filing